Literature DB >> 11727258

MUC4 expression is increased in dysplastic cervical disorders.

A López-Ferrer1, F Alameda, C Barranco, M Garrido, C de Bolós.   

Abstract

The female uterine cervix has 2 characteristic populations of epithelial cells: the endocervix is composed by mucus-secreting cells that express several mucin genes, and the exocervix has a typical stratified squamous epithelium and does not express secreted mucins. Among human mucin genes, the MUC4 sequence has a transmembrane domain, and its molecular structure suggests that it has a protective role and also may be implicated in intracellular signalling. The aim of this study is to analyze whether changes in the expression of MUC4 can be detected associated with the squamous dysplastic transformation of exocervical epithelium. MUC4 expression has been analyzed by immunohistochemistry, Western blotting, and in situ hybridization. Using immunohistochemical techniques, MUC4 is found in normal endocervix (n = 11) and is absent or only focally detected in the normal stratified cervical epithelium (n = 18). In samples from squamous metaplasia (n = 9), MUC4 is variably expressed (10% to 50% positive cells), whereas MUC4 is strongly detected in dysplastic cervical epithelia. The greatest number of positive cells is found in samples with moderate and severe dysplasia in which MUC4 is detected in 100% of the analyzed samples (n = 16). These results have been confirmed by Western blotting and by detection of MUC4 transcripts using in situ hybridization. The present data suggest that MUC4 is activated during the process of squamous dysplastic transformation and may be used as a marker for this pathologic process. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727258     DOI: 10.1053/hupa.2001.28938

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.

Authors:  D A Bax; J Haringsma; A W C Einerhand; H van Dekken; P Blok; P D Siersema; E J Kuipers; J G Kusters
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

2.  MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.

Authors:  M P Ponnusamy; I Lakshmanan; M Jain; S Das; S Chakraborty; P Dey; S K Batra
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

3.  Upregulation of MUC4 in cervical squamous cell carcinoma: pathologic significance.

Authors:  Elizabeth G Munro; Maneesh Jain; Esther Oliva; Neel Kamal; Subodh M Lele; Maureen P Lynch; Lankai Guo; Kai Fu; Poonam Sharma; Steve Remmenga; Whitfield B Growdon; John S Davis; Bo R Rueda; Surinder K Batra
Journal:  Int J Gynecol Pathol       Date:  2009-03       Impact factor: 2.762

4.  Functional MUC4 suppress epithelial-mesenchymal transition in lung adenocarcinoma metastasis.

Authors:  Liuwei Gao; Jun Liu; Bin Zhang; Hua Zhang; Daowei Wang; Tiemei Zhang; Yang Liu; Changli Wang
Journal:  Tumour Biol       Date:  2013-09-15

5.  Expression of Mucin 4 in leukoplakia and oral squamous cell carcinoma: An immunohistochemical study.

Authors:  Sangeetha Narashiman; Malathi Narasimhan; Ganesh Venkatraman
Journal:  J Oral Maxillofac Pathol       Date:  2014-01

6.  Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer.

Authors:  Yuexun Xu; Hui Luo; Qunchao Hu; Haiyan Zhu
Journal:  Front Genet       Date:  2021-02-16       Impact factor: 4.599

Review 7.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

8.  MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells.

Authors:  M P Ponnusamy; A P Singh; M Jain; S Chakraborty; N Moniaux; S K Batra
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.